RATIONALE: Previous studies in rats showed that postnatal day (P)11-20 exposure to +/-3,4-methylenedioxymethamphetamine (MDMA, ecstasy) causes learning and memory deficits in adulthood. The emergence and permanence of these learning deficits are currently unknown. OBJECTIVE: This study was designed to investigate learning and memory deficits in adolescent (P30 or P40) and older (P180 or P360) rats exposed to MDMA from P11-20. MATERIALS AND METHODS: Within each litter half the animals were exposed to MDMA (20 mg/kg) and half to saline (SAL) twice a day (8 h apart) from P11-20. In experiment (exp) 1, behavioral testing began on either P30 or P40, whereas in exp 2, testing began on either P180 or P360. Offspring were tested in the Cincinnati water maze (CWM), a test of path integration learning (2 trials/day for 5 days), and the Morris water maze (MWM) (three phases, with 5 days of 4 trials/day and a probe trial on the sixth day per phase). RESULTS: MDMA-treated rats took longer to find the platform and traveled a greater distance to find the platform at all ages tested in all phases of the MWM. MDMA-treated animals also spent less time in the target quadrant during probe trials. In the CWM, P30 and P40 animals took longer to find the goal and committed more errors in locating the goal, while P180 and P360 MDMA-treated animals performed similarly to SAL-treated animals. CONCLUSION: The data suggest that the spatial learning and memory deficits induced by MDMA are long lasting, while the path integration deficits recover over time.
RATIONALE: Previous studies in rats showed that postnatal day (P)11-20 exposure to +/-3,4-methylenedioxymethamphetamine (MDMA, ecstasy) causes learning and memory deficits in adulthood. The emergence and permanence of these learning deficits are currently unknown. OBJECTIVE: This study was designed to investigate learning and memory deficits in adolescent (P30 or P40) and older (P180 or P360) rats exposed to MDMA from P11-20. MATERIALS AND METHODS: Within each litter half the animals were exposed to MDMA (20 mg/kg) and half to saline (SAL) twice a day (8 h apart) from P11-20. In experiment (exp) 1, behavioral testing began on either P30 or P40, whereas in exp 2, testing began on either P180 or P360. Offspring were tested in the Cincinnati water maze (CWM), a test of path integration learning (2 trials/day for 5 days), and the Morris water maze (MWM) (three phases, with 5 days of 4 trials/day and a probe trial on the sixth day per phase). RESULTS:MDMA-treated rats took longer to find the platform and traveled a greater distance to find the platform at all ages tested in all phases of the MWM. MDMA-treated animals also spent less time in the target quadrant during probe trials. In the CWM, P30 and P40 animals took longer to find the goal and committed more errors in locating the goal, while P180 and P360 MDMA-treated animals performed similarly to SAL-treated animals. CONCLUSION: The data suggest that the spatial learning and memory deficits induced by MDMA are long lasting, while the path integration deficits recover over time.
Authors: Matthew R Skelton; Tracy L Blankenmeyer; Gary A Gudelsky; Carrie A Brown-Strittholt; Charles V Vorhees; Michael T Williams Journal: Synapse Date: 2004-12-15 Impact factor: 2.562
Authors: Andrew B Scholey; Andrew C Parrott; Tom Buchanan; Thomas M Heffernan; Jonathan Ling; Jacqui Rodgers Journal: Addict Behav Date: 2004-06 Impact factor: 3.913
Authors: Matthew R Skelton; Jessica A Able; Curtis E Grace; Nicole R Herring; Tori L Schaefer; Gary A Gudelsky; Charles V Vorhees; Michael T Williams Journal: Neuropharmacology Date: 2008-07-12 Impact factor: 5.250
Authors: Matthew R Skelton; Devon L Graham; Tori L Schaefer; Curtis E Grace; Amanda A Braun; Lindsey N Burns; Robyn M Amos-Kroohs; Michael T Williams; Charles V Vorhees Journal: Int J Neuropsychopharmacol Date: 2011-06-28 Impact factor: 5.176
Authors: Tori L Schaefer; Matthew R Skelton; Nicole R Herring; Gary A Gudelsky; Charles V Vorhees; Michael T Williams Journal: J Neurochem Date: 2007-11-06 Impact factor: 5.372
Authors: Charles V Vorhees; Tori L Schaefer; Matthew R Skelton; Curtis E Grace; Nicole R Herring; Michael T Williams Journal: Dev Neurosci Date: 2009-04-17 Impact factor: 2.984
Authors: Devon L Graham; Nicole R Herring; Tori L Schaefer; Charles V Vorhees; Michael T Williams Journal: Neurotoxicol Teratol Date: 2009-09-06 Impact factor: 3.763